e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
COPD and infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severity-related microbiome changes in COPD
M. Garcia-Nuñez, L. Millares, V. Perez-Brocal, R. Ferrari, M. Gallego, C. Monton, J. Pomares, M. Espasa, A. Mira, A. Moya, E. Monso (Sabadell, Bunyola (Mallorca), Valencia, Spain)
Source:
Annual Congress 2013 –COPD and infections
Session:
COPD and infections
Session type:
Oral Presentation
Number:
3318
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Garcia-Nuñez, L. Millares, V. Perez-Brocal, R. Ferrari, M. Gallego, C. Monton, J. Pomares, M. Espasa, A. Mira, A. Moya, E. Monso (Sabadell, Bunyola (Mallorca), Valencia, Spain). Severity-related microbiome changes in COPD. Eur Respir J 2013; 42: Suppl. 57, 3318
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Preliminary data from a longitudinal study of the airway microbiome in COPD
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015
The species-specific inflammatory response of colonising bacteria in stable COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Longitudinal changes in COPD patients in primary care
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Are there any differences between Tunisian and European COPD phenotypes?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Changes in cognitive status across clinical stages in COPD
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015
COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
The study of airway microbiome and mycobiome of COPD and AECOPD patients
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
COPD assessment for symptoms and functional condition in pulmonary rehabilitation
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
What should be part of a comprehensive assessment of COPD?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Source: Annual Congress 2013 –COPD treatment
Year: 2013
A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept